SURPASS EARLY: A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes

Professor Thozhukat Sathyapalan T.Sathyapalan@hull.ac.uk
Professor of Diabetes, Endocrinology and Metabolism

Esperion ETC 1002 Study Nov 1, 2016 - Mar 31, 2019

PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment Nov 1, 2016 - Oct 31, 2019
Primary objective:
To compare the effect of once-daily dosing of 14 mg oral semaglutide versus placebo, both in combination with metformin and/or sulfonylurea, basal insulin alone or metformin in combination with basal insulin on glycaemic control i... Read More about PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment.

A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS) Jan 11, 2017 - Jan 10, 2018

Liberates: Improving glucose control in patients with diabetes following myocardial infarction: The role of a novel glycaemic monitoring strategy Aug 1, 2017 - Jul 31, 2020

IVF Study 1: Does Insulin or Endocrine Disruptor levels affect fertility? Jan 1, 2014 - Dec 31, 2018